(Total Views: 547)
Posted On: 03/01/2024 8:52:57 PM
Post# of 148870
Re: chazzledazzle #141402
This mechanism of action of binding competitively to the CCR5 receptor differentiates leronlimab from all other CCR5 antagonists.”
Investors Hangout: https://investorshangout.com/post/view?id=667...z8THKxsB8o
I sometimes cannot believe the market and so called big pharma is so slow witted about the potency and range of LL as a therapeutic. Patience Bunky.
Investors Hangout: https://investorshangout.com/post/view?id=667...z8THKxsB8o
I sometimes cannot believe the market and so called big pharma is so slow witted about the potency and range of LL as a therapeutic. Patience Bunky.
(6)
(0)Scroll down for more posts ▼
